Phibro Animal Health Co. (NASDAQ:PAHC) Given Average Recommendation of “Reduce” by Brokerages

Phibro Animal Health Co. (NASDAQ:PAHC) has received a consensus rating of “Reduce” from the five ratings firms that are currently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell recommendation and three have given a hold recommendation to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $20.80.

Several brokerages have recently commented on PAHC. Wall Street Zen raised Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Friday, May 9th. BNP Paribas Exane raised Phibro Animal Health from an “underperform” rating to a “neutral” rating and set a $24.00 price target on the stock in a research note on Monday. Finally, Morgan Stanley boosted their price target on Phibro Animal Health from $20.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 8th.

Phibro Animal Health Stock Performance

NASDAQ PAHC opened at $24.41 on Monday. The company has a current ratio of 3.20, a quick ratio of 1.37 and a debt-to-equity ratio of 2.99. The business’s 50 day moving average is $21.25 and its two-hundred day moving average is $21.88. Phibro Animal Health has a 12-month low of $16.16 and a 12-month high of $26.55. The stock has a market capitalization of $989.23 million, a price-to-earnings ratio of 49.85, a PEG ratio of 0.45 and a beta of 0.74.

Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.52 by $0.11. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. The company had revenue of $347.80 million for the quarter, compared to analysts’ expectations of $352.41 million. Research analysts expect that Phibro Animal Health will post 1.95 EPS for the current year.

Phibro Animal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Wednesday, June 4th will be given a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, June 4th. This represents a $0.48 dividend on an annualized basis and a yield of 1.97%. Phibro Animal Health’s payout ratio is currently 61.54%.

Hedge Funds Weigh In On Phibro Animal Health

Several large investors have recently modified their holdings of PAHC. Sterling Capital Management LLC increased its stake in shares of Phibro Animal Health by 2.4% in the fourth quarter. Sterling Capital Management LLC now owns 18,762 shares of the company’s stock worth $394,000 after purchasing an additional 448 shares during the period. Rhumbline Advisers increased its stake in shares of Phibro Animal Health by 0.6% in the fourth quarter. Rhumbline Advisers now owns 76,582 shares of the company’s stock worth $1,608,000 after purchasing an additional 484 shares during the period. Los Angeles Capital Management LLC increased its stake in shares of Phibro Animal Health by 2.1% in the fourth quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company’s stock worth $505,000 after purchasing an additional 503 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Phibro Animal Health by 4.7% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 12,164 shares of the company’s stock worth $260,000 after purchasing an additional 546 shares during the period. Finally, New York State Teachers Retirement System increased its stake in shares of Phibro Animal Health by 16.7% in the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock worth $114,000 after purchasing an additional 775 shares during the period. Institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.